Epicyt Pharma

Epicyt

This pharmaceutical company develops a drug candidate to improve intestinal calcium absorption for patients who have undergone gastric bypass surgery.

Entera Bio

This biopharmaceutical company develops oral tablet versions of peptide and protein replacement therapies for patients with osteoporosis, hypoparathyroidism, and other metabolic conditions.

Skeletalis

This biotechnology company develops bone-targeted small-molecule therapies for patients with osteoporosis and other musculoskeletal diseases.

Epitome Therapeutics

This biotechnology firm develops an epigenome editing platform for programmable gene expression to treat patients with rare genetic and metabolic disorders.

Epicrispr

This company develops epigenomic therapies to control gene expression in patients with complex diseases.

BOOST Pharma

This company develops an off-the-shelf therapy to treat children born with severe osteogenesis imperfecta, also known as brittle bone disease.

Moroxite F

This company develops regenerative medicine solutions to improve implant anchorage in osteoporotic bone for patients undergoing orthopaedic surgery.

Radius Health

This biopharmaceutical company develops and commercialises endocrine therapies for patients with osteoporosis and other bone health conditions.